Dr. Reddy's Laboratories Ltd. closed 21.94% below its 52-week high of 1,420.20 rupees, which the company achieved on August ...

January 24, 2025 Indian drugmaker Dr Reddy's shares slide after Q3 profit ... the world's media organizations, industry events and directly to consumers.

Dr. Reddy's Laboratories Ltd. closed 23.35% short of its 52-week high of 1,420.20 rupees, which the company reached on August ...

Year to date, shares of Dr. Reddy’s have gained 1.6% compared with the industry’s 12.5% growth. Image Source: Zacks Investment Research Dr. Reddy’s has undertaken multiple strategic ...

India's Dr Reddy's Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an ...

With this partnership, they aim to enhance access to affordable treatments for patients suffering from autoimmune diseases ...

Hyderabad: The Income Tax Department has issued a show cause notice to Dr Reddy's Laboratories Limited, proposing a tax ...

China's Bio-Thera Solutions has entered into an exclusive commercialization agreement with India's Dr. Reddy's Laboratories ...

Dr. Reddy’s Laboratories Ltd. (BSE ... As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future.

Large mergers and acquisitions in the Indian pharmaceutical market are unlikely soon due to various uncertainties, says GV Prasad of Dr Reddy's Laboratories. The company is focusing on diversifying ...

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together ...

HYDERABAD, India & REYKJAVIK, Iceland, March 18, 2025--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along ...